Pesquisar
Celldex Therapeutics Inc
CLDXAdicionar à lista de desejos
37.840USD
-1.140-2.92%
Horário de mercado 09/18, 14:31（ET）
2.97BValor de mercado
PerdaP/L TTM
Mais detalhes de Celldex Therapeutics Inc Empresa
Celldex Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases. Its Barzolvolimab (CDX-0159) is a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is being studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis, Atopic Dermatitis and Eosinophilic Esophagitis. The Company’s bispecific platform includes CDX- 622. The CDX- 622 is a bispecific candidate for inflammatory diseases.
Celldex Therapeutics Inc Perfil
Código da empresaCLDX
Nome da EmpresaCelldex Therapeutics Inc
Data de listagemMay 15, 1986
CEOMarucci (Anthony S)
Número de funcionários186
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 15
Endereço53 Frontage Road
CidadeHAMPTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08827
Telefone19084547120
Sitehttps://celldex.com/
Código da empresaCLDX
Data de listagemMay 15, 1986
CEOMarucci (Anthony S)
Executivos da empresa Celldex Therapeutics Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Dr. Ronald A. Pepin, Ph.D.
Dr. Ronald A. Pepin, Ph.D.
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
19.33K
--
Dr. Ronald A. Pepin, Ph.D.
Dr. Ronald A. Pepin, Ph.D.
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
19.33K
--
Dr. Ronald A. Pepin, Ph.D.
Dr. Ronald A. Pepin, Ph.D.
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
19.33K
--
Dr. Margo Heath-Chiozzi, M.D.
Dr. Margo Heath-Chiozzi, M.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
14.29K
+3.83%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Anthony S. Marucci
Mr. Anthony S. Marucci
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.67K
+2.48%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Mr. Freddy A. Jimenez, Esq., J.D.
Mr. Freddy A. Jimenez, Esq., J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
29.20K
-14.27%
Perguntas frequentes
Quem são os cinco principais acionistas de Celldex Therapeutics Inc?
Os cinco principais acionistas de Celldex Therapeutics Inc são: Mr. Anthony S. Marucci
Quantas instituições possuem ações da Celldex Therapeutics Inc (CLDX)?
Em 2026Q1, 428 instituições possuíam ações da Celldex Therapeutics Inc, com valor de mercado aproximado de 75.58M, representando 96.30% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -6465015.00.